Semaglutide 5mg × 10
Research-use disclaimer
All products are strictly for laboratory research and in-vitro studies, not for human consumption.
Description
Semaglutide is a GLP-1 receptor agonist used for fat loss and blood glucose control. It achieves weight management by suppressing appetite and delaying gastric emptying.
Effects
Suppresses appetite, reduces calorie intake; delays gastric emptying, increases satiety; promotes insulin secretion, lowers blood glucose; improves insulin sensitivity; effectively reduces body weight, decreases waist circumference.
Usage
Subcutaneous injection once weekly. Starting dose: 0.25 mg for 4 weeks; then increase every 4 weeks, maintenance dose: 2.4 mg (for fat loss). Specific cycle follow doctor's advice. Reconstitute before use (if lyophilized powder).
Suitable for
Adults with obesity or overweight accompanied by weight-related complications (e.g., hypertension, type 2 diabetes, hyperlipidemia); patients with type 2 diabetes requiring weight management.
Not suitable for
Individuals allergic to Semaglutide or excipients; those with personal or family history of medullary thyroid carcinoma; patients with multiple endocrine neoplasia syndrome type 2; patients with severe gastrointestinal diseases (e.g., gastroparesis); pregnant and breastfeeding women.
Ingredients
Semaglutide
Storage
Store refrigerated at 2-8°C, do not freeze, protect from light.
Shelf life
24 months
Product research FAQ
What is this product intended for?
It is supplied strictly for laboratory research and in-vitro studies, not for human consumption.
Is batch documentation available?
Available batch-specific Certificates of Analysis are listed in the COA section on this page.
How should the product be stored?
Follow the storage information shown on this page and the instructions supplied with the specific batch.
